|
US4278633A
|
|
Method of treating a water soluble capsule
|
|
US4191779A
|
|
Method of treating bacterial infections
|
|
US4147802A
|
|
Method of treating bacterial infections
|
|
DE2645492A1
|
|
Guanidinoacyl histidines protect agst. coccic and bacillic infections - in mammals esp. against staphylococcal infections
|
|
GB1567644A
|
|
Methods and compositions for inducing resistance to bacterial infections
|
|
CA1076123A
|
|
Omega-guanidinoacyl-l-histidines
|
|
DE2538182A1
|
|
Fibrinolytic aminoalkane sulphonic acids - prepd. e.g. from dibromoalkane and sodium sulphite and ammonia
|
|
US3995051A
|
|
Methods and compositions for inducing resistance to bacterial infections
|
|
GB1466616A
|
|
Methods and compositions for inducing resistance to bacterial infections
|
|
DE2441777A1
|
|
Antibacterial omega guanidino acids - useful for treating bacterial and coccic infections
|
|
NL7411216A
|
|
Antibacterial omega guanidino acids - useful for treating bacterial and coccic infections
|
|
CA1041014A
|
|
Methods and compositions for inducing resistance to bacterial infections
|
|
US3920833A
|
|
Antifibrinolytic agents
|
|
US3899589A
|
|
Method and compositions for inducing resistance to bacterial infections
|
|
CA1010785A
|
|
Antimicrobial compositions containing taurine or cysteic acid
|
|
DE2319106A1
|
|
Taurine as antimicrobial - for prophylactic purposes
|
|
GB1430157A
|
|
Methods and compositions for inducing resistance to bacterial infections
|
|
US3843798A
|
|
Methods and compositions for inducing resistance to bacterial infections
|
|
US3943244A
|
|
Anti-microbial factors effective against bacillic and coccic infections
|
|
GB1354622A
|
|
Aminoacylhistidine derivatives
|
